Aligos Therapeutics (ALGS)
(Delayed Data from NSDQ)
$0.78 USD
-0.04 (-4.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $0.79 +0.01 (1.02%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, Aligos Therapeutics (ALGS) reported earnings of -$0.22 per share, beating the Zacks Consensus Estimate of $-0.27 per share. This reflects a positive earnings surprise of 18.52%. Look out for ALGS's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 64.15%.
Earnings History
Price & Consensus
Zacks News for ALGS
Certara, Inc. (CERT) Lags Q4 Earnings Estimates
ALGS: What are Zacks experts saying now?
Zacks Private Portfolio Services